Ultragenyx Pharmaceutical Inc. (FRA:UP0)
Germany
· Delayed Price · Currency is EUR 31.20
+2.60 (9.09%)
Last updated: Dec 4, 2025, 8:07 AM CET
Revenue by Geography
Fiscal year is January - December.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2017 - 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2017 - 2020 |
| North America Revenue | 361.23M | 340.46M |
Log In |
Log In |
Log In | Upgrade
|
| Latin America Revenue | 149.78M | 130.71M |
Log In |
Log In |
Log In | Upgrade
|
| Europe Revenue | 103.38M | 80.12M |
Log In |
Log In |
Log In | Upgrade
|
| Asia-Pacific Revenue | 16.21M | 8.93M |
Log In |
Log In |
Log In | Upgrade
|
| Revenue (Total) | 630.60M | 560.23M |
Log In |
Log In |
Log In | Upgrade
|
Revenue
Fiscal year is January - December.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2017 - 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2017 - 2020 |
| Crysvita Revenue | 159.23M | 134.71M |
Log In |
Log In |
Log In | Upgrade
|
| Dojolvi Revenue | 95.59M | 88.19M |
Log In |
Log In |
Log In | Upgrade
|
| Evkeeza Revenue | 52.70M | 32.16M |
Log In |
Log In |
Log In | Upgrade
|
| Mepsevii Revenue | 31.67M | 30.35M |
Log In |
Log In |
Log In | Upgrade
|
| Total Product Revenue | 339.19M | 285.42M |
Log In |
Log In |
Log In | Upgrade
|
| Crysvita Royalty Revenue | 291.41M | 274.82M |
Log In |
Log In |
Log In | Upgrade
|
| Crysvita Collaboration Revenue in Profit-Share Territory | - | - |
Log In |
Log In |
Log In | Upgrade
|
| Crysvita Royalty Revenue in European Territory | - | - |
Log In |
Log In |
Log In | Upgrade
|
| Daiichi Sankyo Revenue | - | - |
Log In |
Log In |
Log In | Upgrade
|
| Total Collaboration and License Revenue | - | - |
Log In |
Log In |
Log In | Upgrade
|
| Revenue (Other) | -52.70M | -32.16M |
Log In |
Log In |
Log In | Upgrade
|
| Revenue (Total) | 630.60M | 560.23M |
Log In |
Log In |
Log In | Upgrade
|